drug industry org
Corroborated stories featuring this entity · 4
The US launched a Section 301 investigation into Germany over pharmaceutical pricing policies.
The US launched a Section 301 investigation into Germany over pharmaceutical pricing policies.
otherwestern
The US argues that Germany's pharmaceutical pricing policies unfairly underpay for innovative medicines and burden US commerce.
otherwestern
The US launched a Section 301 probe into Germany over pharmaceutical pricing.
The US launched a Section 301 probe into Germany over pharmaceutical pricing.
otherwestern
The US is examining whether Germany's pharmaceutical pricing practices unfairly underpay for innovative medicines.
otherwestern
The U.S. investigation could pave the way for new tariffs on German goods.
The U.S. investigation could pave the way for new tariffs on German goods.
otherwestern
The U.S. Trade Representative initiated an investigation under Section 301 of the Trade Act of 1974 against Germany.
other
The U.S. Trade Representative initiated an investigation under Section 301 of the Trade Act of 1974 against Germany.
The U.S. Trade Representative initiated an investigation under Section 301 of the Trade Act of 1974 against Germany.
otherwestern
The investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory and burdens or restricts U.S. commerce.
other